- Home
- CLBR vs BLDE Comparison
CLBR vs BLDE Comparison
Compare CLBR & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBR
- BLDE
- Stock Information
- Founded
- CLBR 2023
- BLDE 2014
- Country
- CLBR United States
- BLDE United States
- Employees
- CLBR N/A
- BLDE N/A
- Industry
- CLBR
- BLDE Aerospace
- Sector
- CLBR
- BLDE Consumer Discretionary
- Exchange
- CLBR Nasdaq
- BLDE Nasdaq
- Market Cap
- CLBR 226.0M
- BLDE 272.5M
- IPO Year
- CLBR 2023
- BLDE N/A
- Fundamental
- Price
- CLBR $10.91
- BLDE $2.80
- Analyst Decision
- CLBR
- BLDE Strong Buy
- Analyst Count
- CLBR 0
- BLDE 2
- Target Price
- CLBR N/A
- BLDE $6.25
- AVG Volume (30 Days)
- CLBR 178.6K
- BLDE 681.6K
- Earning Date
- CLBR 01-01-0001
- BLDE 03-13-2025
- Dividend Yield
- CLBR N/A
- BLDE N/A
- EPS Growth
- CLBR N/A
- BLDE N/A
- EPS
- CLBR 0.27
- BLDE N/A
- Revenue
- CLBR N/A
- BLDE $248,693,000.00
- Revenue This Year
- CLBR N/A
- BLDE $5.29
- Revenue Next Year
- CLBR N/A
- BLDE $8.99
- P/E Ratio
- CLBR $39.30
- BLDE N/A
- Revenue Growth
- CLBR N/A
- BLDE 10.44
- 52 Week Low
- CLBR $10.15
- BLDE $2.60
- 52 Week High
- CLBR $12.28
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- CLBR 67.12
- BLDE 35.51
- Support Level
- CLBR $10.60
- BLDE $2.65
- Resistance Level
- CLBR $10.74
- BLDE $3.21
- Average True Range (ATR)
- CLBR 0.09
- BLDE 0.19
- MACD
- CLBR 0.03
- BLDE -0.00
- Stochastic Oscillator
- CLBR 89.47
- BLDE 13.39
About CLBR Colombier Acquisition Corp. II
Colombier Acquisition Corp II is a blank check company.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.